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Abstract
Identifying genetic factors that modify an individual's susceptibility to cognitive
decline in aging is critical to understanding biological processes involved and miti-
gating risk associated with a number of age‐related disorders. Recently, heterochro-
matin protein 1 binding protein 3 (Hp1bp3) was identified as a mediator of cognitive
aging. Here, we provide a mechanistic explanation for these findings and show that
targeted knockdown of Hp1bp3 in the hippocampus by 50%–75% is sufficient to
induce cognitive deficits and transcriptional changes reminiscent of those observed
in aging and Alzheimer's disease brains. Specifically, neuroinflammatory‐related path-
ways become activated following Hp1bp3 knockdown in combination with a robust
decrease in genes involved in synaptic activity and neuronal function. To test the
hypothesis that Hp1bp3 mediates susceptibility to cognitive deficits via a role in
neuronal excitability, we performed slice electrophysiology demonstrate transcrip-
tional changes after Hp1bp3 knockdown manifest functionally as a reduction in hip-
pocampal neuronal intrinsic excitability and synaptic plasticity. In addition, as
Hp1bp3 is a known mediator of miRNA biogenesis, here we profile the miRNA tran-
scriptome and identify mir‐223 as a putative regulator of a portion of observed
mRNA changes, particularly those that are inflammatory‐related. In summary, work
here identifies Hp1bp3 as a critical mediator of aging‐related changes at the pheno-
typic, cellular, and molecular level and will help inform the development of thera-
peutics designed to target either Hp1bp3 or its downstream effectors in order to
promote cognitive longevity.
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1 | INTRODUCTION
Most individuals will experience some degree of cognitive decline
during aging, although the extent of this decline can vary widely. As
aging is the leading risk factor for many neurodegenerative diseases,
including Alzheimer's, it is critical to understand why some individu-
als are at increased risk for age‐related cognitive decline and even-
tual dementia. Studies suggest up to 60%–70% of the variation
observed in cognitive abilities during aging are attributable to genetic
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factors (McClearn et al., 1997), although precise variants involved
have been difficult to identify. Recently, our laboratory identified
heterochromatin protein 1 binding protein 3 (Hp1bp3) as a modifier
of cognitive aging in mice (Neuner et al., 2016). Using a forward
genetics screen in the BXD genetic reference panel, we identified a
quantitative trait locus (QTL) on chromosome 4 which harbored vari-
ants responsible for variation in cognitive abilities at midlife. Using a
combination of bioinformatics and functional validation approaches,
Hp1bp3 emerged as a likely gene candidate responsible for mediat-
ing the QTL effect. Specifically, strains harboring the DBA2/J (D2)
allele of Hp1bp3 exhibited decreased Hp1bp3 gene expression in the
hippocampus in combination with exacerbated cognitive aging. This
relationship between decreased Hp1bp3 and reduced cognitive func-
tion was observed in the Hp1bp3 knockout mouse as well as aging
impaired humans (Neuner et al., 2016). However, the mechanistic
link between Hp1bp3 and regulation of cognitive function remains to
be elucidated. Therefore, the goal of this study was to better under-
stand how Hp1bp3 influences cognitive function under baseline con-
ditions in adult animals by using virally encoded shRNA targeting
Hp1bp3 designed to reduce expression similar to that observed in
aging impaired individuals.
Hp1bp3 is a heterochromatin binding protein that is related to
the histone H1 family of proteins (Garfinkel, Melamed‐Book, Anuka,
Bustin, & Orly, 2015). It has been implicated in a variety of func-
tions, most notably selective regulation of gene expression via a role
in the modulation of chromatin structure (Dutta et al., 2014) and
micro‐RNA (miRNA) biogenesis in human cells (Liu et al., 2016). In
our previous study, enrichment analysis of the hippocampal tran-
scriptome in relation to Hp1bp3 identified negative correlates of
Hp1bp3 significantly enriched for localization to the plasma mem-
brane, with functional annotations including ion channel activity and
G‐protein coupled receptor activity (Neuner et al., 2016). Plasma
membrane ion channels and receptors are critical regulators of neu-
ronal excitability and synaptic plasticity, leading candidate mecha-
nisms for memory storage (Kandel, 2001). Taken together, this
information led us to hypothesize that Hp1bp3 may be mediating its
effects on cognitive longevity via the modulation of hippocampal
neuronal excitability.
Synaptic plasticity mechanisms such as long‐term potentiation
(LTP) have been identified as leading molecular and cellular mecha-
nisms of memory storage based on their properties of that include
input specificity and associativity (Bliss & Collingridge, 1993). Intrin-
sic neuronal excitability is intimately linked to these processes, as
changes in the intrinsic excitability of a neuron will influence its abil-
ity to respond to input—ultimately influencing synaptic throughput
and the ability of a neural network to undergo long‐lasting changes
such as LTP (Zhang & Linden, 2003). Multiple lines of evidence sup-
port the contention that these mechanisms are critical for learning
and memory. For example, aged cognitively impaired rodents exhibit
significantly decreased intrinsic neuronal excitability relative to
young or nonimpaired controls (Kaczorowski & Disterhoft, 2009),
and pharmacological agents that block LTP have also been observed
to impair cognitive function (Abraham & Mason, 1988).
De novo gene transcription is a fundamental biological process
underlying LTP and corresponding modification of synapses. Upon
neuronal activation, a highly specific cascade of gene transcription is
initiated that, under the right conditions, results in stable and long‐
lasting functional changes including synaptic localization of ion chan-
nels and receptors as well as growth and morphological alterations
of both axons and dendrites (Gutierrez & Davies, 2011). As with LTP
itself, multiple lines of evidence support the notion that gene tran-
scription is critical for successful memory formation and consolida-
tion, including studies that have demonstrated amnesic effects
resulting from blocking mRNA synthesis (Da Silva et al., 2008). Mul-
tiple classes of genes have been implicated in plasticity‐related tran-
scription, including transcription factors such as the cAMP‐response
element‐binding protein (CREB) family and immediate early genes
such as the activity‐regulated cytoskeleton‐associated protein (Arc)
and c‐Fos (Alberini & Kandel, 2014).
However, it remains to be elucidated exactly how these tran-
scriptional programs are activated and how variation in de novo
gene transcription under baseline conditions may contribute to cog-
nitive impairment. The precise nature of activity‐related gene tran-
scription implicates modification of chromatin structure as critical for
memory formation and consolidation, as specific genes need to be
accessible by transcriptional machinery at defined intervals.
Here, we assess the effects of a hippocampus‐specific knock-
down (KD) of Hp1bp3 on cognitive function, the hippocampal tran-
scriptome, neuronal excitability, and synaptic plasticity. We perform
these experiments in both the C57BL6/J (B6) and D2 inbred mouse
strains to enhance the rigor of our approach, as recent findings sug-
gest studies conducted in a single genetic background limit the gen-
eralizability of mouse studies (Sittig et al., 2016). We chose these
two strains as they are the parental lines of the BXD genetic refer-
ence panel that was originally used to discover Hp1bp3 as a modifier
of cognitive aging (Neuner et al., 2016; Peirce, Lu, Gu, Silver, & Wil-
liams, 2004). In addition, the B6 and D2 strains show marked pheno-
type differences in a variety of domains, including both cognitive
function and hippocampal neuronal excitability (Matsuyama, Nam-
gung, & Routtenberg, 1997; Nguyen, Abel, Kandel, & Bourtchou-
ladze, 2000; Philip et al., 2010). It was our hypothesis that any
effect of Hp1bp3 KD observed across strains would be robust and
potentially translatable to diverse genetic contexts.
2 | RESULTS
2.1 | Hippocampus‐specific knockdown of Hp1bp3
impairs cognitive function
In order to test the hypothesis that Hp1bp3 modifies cognitive func-
tion through a hippocampus‐specific effect rather than a peripheral
effect (Garfinkel, Arad, et al., 2015), we designed an adeno‐associ-
ated virus serotype 9 (AAV9) viral vector encoding either shRNA for
Hp1bp3 or a scrambled (scrmb) control and delivered 1.0 µl bilater-
ally to the dorsal hippocampus of adult (3–6 months) B6 and D2
mice (Figure 1a). Efficacy of the viral vector to reduce HP1BP3
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levels was confirmed via western blot (Figure 1b). Notably, no reduc-
tion in HP1BP3 levels was observed in the cortex or cerebellum,
indicating minimal viral spread outside our target region (Supporting
Information Figure S1). Four to six weeks following injection, we
assessed both working and long‐term contextual fear memory in
these mice. There was a significant effect of Hp1bp3 KD on working
memory as measured in the T‐maze, with both B6 and D2 mice
receiving AAV9‐shRNA‐Hp1bp3 performing worse than their control
counterparts [Figure 1b, two‐way ANOVA, effect of treatment F(1,
41) = 5.9, p = 0.02]. Long‐term contextual fear memory was then
assessed via contextual fear conditioning. Although D2 mice overall
performed more poorly than B6 mice during training, there was no
effect of Hp1bp3 KD on contextual fear acquisition as measured by
freezing during the 40 s following the final shock [Figure 1c, left,
two‐way ANOVA, effect of strain F(1, 39) = 5.4, p = 0.03, effect of
treatment F(1, 39) = 0.12, p = 0.73]. In contrast, there was a signifi-
cant main effect of treatment on contextual fear memory [Figure 1c,
right, two‐way ANOVA, effect of strain F(1, 39) = 56.4, p < 0.001,
effect of treatment, F(1, 39) = 13.6, p = 0.001], suggesting Hp1bp3 is
uniquely involved in mechanisms underlying memory consolidation
and/or recall, but not fear acquisition. This effect was driven by the
B6 strain, as the D2 mice performed so poorly no additional effect
of treatment was observed, as evidenced by a significant interaction
between strain and treatment [interaction between strain and treat-
ment F(1, 39) = 14.5, p < 0.001]. These effects were not due to
nonspecific effects on anxiety, activity, or overall growth as mea-
sured by open‐arm entries on the elevated plus maze, total arm
entries, speed, and weight, respectively (Supporting Information Fig-
ure S2).
2.2 | Hp1bp3 knockdown alters specific aspects of
the hippocampal transcriptome
We next wanted to determine the mechanism(s) by which hippocam-
pal KD of Hp1bp3 may be impairing cognitive function. We per-
formed total RNA sequencing on whole hippocampal lysates from
three mice per strain/treatment group and confirmed knockdown of
Hp1bp3 at the mRNA level (Figure 2a). A subset of genes were iden-
tified to as differentially expressed relative to both strain background
and treatment group, while relatively few genes displayed a signifi-
cant strain by treatment interaction, suggesting Hp1bp3 KD alters
the hippocampal transcriptome comparably across background strain
(Figure 2b and Supporting Information Table S1). To identify specific
pathways and functional categories altered by Hp1bp3 KD, we next
utilized gene set enrichment analysis (GSEA) in order to identify
gene ontology (GO) terms significantly enriched among differentially
expressed genes. Among genes upregulated by Hp1bp3 KD, we iden-
tified a significant enrichment for immune‐related terms, including
response to interferon gamma, chemokine‐mediated signaling, and
response to type I interferon (Figure 2c). This increase in inflamma-
tory signaling seemed to be driven largely by an increase in micro-
glia, as genes upregulated by Hp1bp3 KD that also display a
significant cell type‐specific expression (Zhang et al., 2014) showed a
significant overlap with a list of genes most highly expressed by
microglia (hypergeometric test p < 0.001, Figure 2d). In contrast,
among genes downregulated by Hp1bp3 KD, we identified a signifi-
cant enrichment for a number of terms related to neuron structure
and function, including regulation of neuronal synaptic plasticity,
excitatory synapse, and various channel activity terms (Figure 2e). In
addition, among genes downregulated by Hp1bp3 KD, there was a
significant enrichment for transcripts experimentally observed to be
most highly expressed in neurons and myelinating oligodendrocytes
(hypergeometric test, p < 0.001).
As synaptic plasticity is a leading candidate mechanism for infor-
mation and memory storage, and due to the fact that we identified
regulation of ion channels and receptors as a candidate mechanism
for Hp1bp3‐induced cognitive impairment in an aging mouse popula-
tion (Neuner et al., 2016), we were particularly interested in the
most significantly downregulated GO term, regulation of neuronal
synaptic plasticity. The identification of this pathway was driven by
19 genes strongly downregulated by Hp1bp3 KD (normalized enrich-
ment score = −2.2, FDR = 0.01, Figure 3a). Of these 19 genes, 14
were identified as core driver genes by GSEA. Notably, the core dri-
ver gene most significantly downregulated by treatment, particularly
in B6 mice, was the activity‐regulated cytoskeleton‐associated pro-
tein (Arc), a gene repeatedly implicated in learning and memory but
for whom the upstream regulators remain poorly defined [(Shepherd
& Bear, 2011), Figure 3b]. Additional core driver genes included a
number of ion channels and receptors, including: (a) shisa family
member 9 (Shisa9), an AMPAR auxiliary subunit (von Engelhardt
et al., 2010), (b) junctophilin 3 (Jph3), a transmembrane junctional
protein implicated in the regulation of the slow after‐hyperpolariza-
tion (Moriguchi et al., 2006), (c) brevican (Bcan), an extracellular
matrix protein that regulates the speed of synaptic transmission
(Blosa et al., 2015), and (d) disks large homolog 4 (Dlg4), also known
as postsynaptic density protein 96 (Psd95), which plays a critical role
in organizing postsynaptic signaling (Chen et al., 2011).
2.3 | Hp1bp3 knockdown decreases intrinsic
excitability and synaptic plasticity of hippocampal
neurons
To directly test the validity of the findings that Hp1bp3 KD alters
neuronal excitability and synaptic plasticity, we performed slice elec-
trophysiology to measure the properties of neurons from either
mice receiving AAV9‐shRNA‐Hp1bp3 or AAV9‐scrmb‐shRNA. Specif-
ically, mice were sacrificed at least 6 weeks following viral injection
and brains quickly removed, sectioned, and maintained in aCSF for
recordings. For the subset of mice that were behaviorally tested,
slice electrophysiology occurred at least two weeks after the conclu-
sion of behavioral testing to allow hippocampal neurons to return to
baseline conditions. We first examined intrinsic neuronal properties
and found Hp1bp3 KD significantly increased the slow after‐
hyperpolarization (sAHP) of hippocampal pyramidal neurons [Fig-
ure 4, two‐way ANOVA, effect of treatment F(1,56) = 6.7, p = 0.01,
no main effect of strain]. This seemed to be a relatively specific
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effect, as resting properties such as resting membrane potential and
input resistance of the cell were not altered by knockdown,
although strain‐specific differences were observed (Supporting Infor-
mation Figure S3). In addition, Hp1bp3 KD did not change the
intrinsic firing properties of the neurons, as measured by threshold
required to fire an action potential and the peak after‐hyperpolariza-
tion (Table 1).
In a separate cohort of mice, we next assessed the role of
Hp1bp3 in synaptic plasticity by placing a stimulating electrode in
the Shaffer collateral pathway and eliciting excitatory postsynaptic
potentials (EPSPs) in CA1, measured via whole‐cell recordings (Fig-
ure 4c). Stimulation was titrated so that EPSPs 5 mV in amplitude
were elicited once every 20 s for 5 min to obtain a stable baseline
EPSP measurement. Theta‐burst stimulation (TBS), a paradigm shown
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F IGURE 1 Hippocampus‐specific knockdown of Hp1bp3 impairs cognitive function. (a) 1.0 μl of AAV9 encoding either Hp1bp3 shRNA or a
scrambled control was injected bilaterally into the dorsal hippocampus of adult C57BL/6 J (B6) and DBA/2 J (D2) mice. After 4–6 weeks, a
subset of mice were behaviorally tested. A minimum of two weeks later, mice were either harvested or used for electrophysiology. Mouse
brain image adapted from The Mouse Brain in Stereotaxic Coordinates (Paxinos and Franklin, 2013). (b) Left, efficacy of the viral vector to
reduce HP1BP3 levels in the hippocampus was confirmed via western blot; n = 6/group, two‐way ANOVA effect of strain F(1, 20) = 1.2
p = 0.3, effect of treatment F(1, 20) = 15.6, p = 0.001, no interaction. Right, data from four independent blots (two experiments) were pooled
across strains (n = 12/group) and quantified. Lysate from human 293 T cells overexpressing HP1BP3 was used as a positive control. (c)
Working memory was measured in the T‐maze. A significant effect of treatment was observed F(1, 41) = 5.9, p = 0.02, indicating that Hp1bp3
KD impairs working memory function across B6 and D2 mice. (d) Long‐term memory was assessed using contextual fear conditioning.
Although B6 and D2 mice acquired the task differently on Day 1 [effect of strain, F(1, 39) = 5.4, p = 0.03], Hp1bp3 KD had no effect on the
extent of these differences [effect of treatment, F(1, 39) = 0.12, p = 0.73]. Right, when mice were placed back in the training chamber on Day
2, D2 mice performed significantly worse than B6 mice [effect of strain F(1, 39) = 56.4, p < 0.001]—so poorly that further impairment caused
by Hp1bp3 reduction could not be observed. However, Hp1bp3 KD did impair contextual fear memory in B6 mice [effect of treatment, F(1,
39) = 13.6, p = 0.001, interaction between strain and treatment F(1, 39) = 14.5, p < 0.001]. *main effect of treatment, p < 0.05, **t test,
p < 0.05
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to elicit long‐term potentiation in the Shaffer collateral (Graves,
Moore, Spruston, Tryba, & Kaczorowski, 2016), was delivered imme-
diately following five minutes of baseline recording. EPSPs continued
to be elicited once every 20 s for 35 min to measure the change in
EPSP amplitude post‐TBS. Data were collected and pooled into 5‐
min bins for further analysis (Figure 4d). Mice receiving AAV9‐
Hp1bp3‐shRNA displayed significantly impaired LTP relative to mice
receiving AAV9‐scrmb‐shRNA, particularly at late time points [Fig-
ure 4e‐H]. No significant effects of strain, or interaction between
time and strain, were observed, indicating that Hp1bp3 KD impaired
synaptic plasticity similarly across groups. Notably, Hp1bp3 KD did
not impair baseline characteristics such as intrinsic excitability as
measured by the number of action potentials fired in response to a
1‐s sustained current injection (Supporting Information Figure S4a),
amplitude of EPSPs in response to increasing stimulation intensities
(Supporting Information Figure S4b), or paired pulse ratio (Supporting
Information Figure S4c). In summary, these data demonstrate
Hp1bp3 specifically regulates neuronal excitability and plasticity nec-
essary for successful cognitive performance on both working and
contextual fear memory tasks.
2.4 | Hp1bp3 selectively regulates a subset of
micro‐RNAs
Recent studies have demonstrated that HP1BP3 plays a role in
miRNA biogenesis in human cells in vitro (Liu et al., 2016). To inves-
tigate whether observed transcriptional changes were due to a global
change in miRNA biogenesis, we analyzed the small RNA sequences
generated by our initial total RNA sequencing on hippocampal tissue
from 3 mice/group. Of 1915 miRNAs identified and tested for differ-
ential expression analysis, only 35 showed differential expression rel-
ative to treatment at an adjusted p‐value of 0.10 (Figure 5a and
H
p1
bp
3 
(n
or
m
al
iz
ed
)
Effects of Strain
Differentially expressed genes 2620
Upregulated 1026
Downregulated 1594
Effects of Knockdown 
Differentially expressed genes 1642
Upregulated 901
Downregulated 741
Interaction
Differentially expressed genes 12
Upregulated 3
Downregulated 9
-5 -4 -3 -2 -1 0
Postsynaptic density
Cation channel activity
Excitatory synapse
Neural nucleus development
RNA splicing (transesterification)
Negatively Enriched GO terms
0 1 2 3 4 5 6 7
Positively Enriched GO terms
RNP complex subunit org.
Regulation of synaptic plasticity
VG cation channel activity
VG K+ channel activity
Response to interferon gamma
Chemokine mediated signaling
Response to type I interferon
Cytokine mediated signaling
Chemokine receptor binding
Response to virus
Cellular response to interferon gamma
Defense response to virus
Regulation of symbiosis
Neg. regulation of multi-organism process
Normalized Enrichment Score*-log(FDRq)
Normalized Enrichment Score*-log(FDRq)
(a) (b)
(e)
(c)
*
As
tro
cy
tes EC
Mi
cro
gli
a
My
eli
na
tin
g O
lig
o.
Ne
uro
ns
Ne
w 
Ol
igo
.
OP
C
As
tro
cy
tesEC
Mi
cro
gli
a
My
eli
na
tin
g O
lig
o.
Ne
uro
ns
Ne
w 
Ol
igo
.
OP
C
C
ou
nt
C
ou
nt
300
200
100
0
300
200
100
0
*
*
(f)
(d)
5,000
6,000
7,000
8,000
9,000
Treatment
Ctrl KD
Regulation of neuronal synaptic plasticity
*
*
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Supporting Information Table S2), with only 9 remaining significant
at an adjusted p = 0.05. Thus, <0.5% of all miRNAs tested exhibit
significant differential expression following Hp1bp3 KD. This is in
comparison with mRNA, where just over 7% of all mRNAs tested
were differentially expressed relative to Hp1bp3 KD (proportions of
differentially expressed genes significantly different, Z = 11.5,
p < 0.001), suggesting Hp1bp3 plays a much broader role in the reg-
ulation of mRNA expression over miRNA expression. These results
demonstrate that in contrast to what has been observed in human
cells, Hp1bp3 does not seem to be a global regulator of miRNA bio-
genesis in vivo in the mouse hippocampus.
Although global changes in miRNA expression were not
observed, we next tested the hypothesis that the select miRNAs reg-
ulated by Hp1bp3 may explain downstream observed changes in
mRNA expression and synaptic function. First, we input the list of
mRNAs differentially expressed relative to treatment into Ingenuity
Pathway Analysis (IPA) software (Kramer, Green, Pollard, & Tugen-
dreich, 2014) and used the Core Analysis function to identify puta-
tive miRNA upstream regulators of our observed mRNA changes
(Supporting Information Table S3). A number of miRNAs were identi-
fied as putative upstream regulators, as measured by significant
overlap of known target genes and genes present in our list of dif-
ferentially expressed mRNA. The top predicted upstream regulator,
mir‐21, was predicted to be inhibited in our dataset based on the
direction of change in its target molecules. However, the pattern of
mir‐21 differential expression after Hp1bp3 KD did not fit this pat-
tern, eliminating mir‐21 as a miRNA that could possible explain
mRNA changes observed in our hands (Supporting Information
Table S3). Next, we examined the miRNA identified as the second
most likely miRNA upstream regulator, mir‐223. Based on the direc-
tion of change of its target molecules, IPA predicted that mir‐223
was activated in our dataset, and indeed, mir‐223 (specifically mmu‐
mir‐223‐3p) was observed to be upregulated after Hp1bp3 KD (two‐
way ANOVA, effect of treatment F(1, 8) = 5.6, p = 0.046, Figure 5b)
and was one of the miRNA transcripts identified as significantly dif-
ferentially expressed by DESeq2 at an adjusted p = 0.10 (mmu‐mir‐
223‐3p adjusted p = 0.09, log2FC = 1.2). mir‐223, best studied in
the context of hematopoietic stem cells, has been shown to function
as a key modulator in the differentiation and activation of myeloid
cells and has been implicated in a number of immune system func-
tions (Yuan et al., 2018). In accordance with these known functions,
the list of mir‐223 targets differentially expressed after Hp1bp3 KD
was identified to be most highly enriched for the GO Biological Pro-
cess term “immune system process” (FDR < 0.001) through Web-
Gestalt over‐representation enrichment analysis (Wang, Duncan, Shi,
& Zhang, 2013). Notably, mir‐223 has been shown to promote matu-
ration, proliferation, and activation of myeloid cells (Tsitsiou & Lind-
say, 2009), which overlaps with our previous observation that the
upregulation of immune‐related genes following Hp1bp3 KD is likely
due to an increase in numbers of microglia (Figure 2d).
2.5 | Transcriptome‐level changes induced by
Hp1bp3 knockdown recapitulate those observed in
human aging
In addition to standard GO terms and functional pathways, GSEA
also allows gene lists of interest to be compared against experimen-
tally derived gene sets that have been uploaded into the Molecular
Signatures Database (Liberzon et al., 2011). When we compared our
list of differentially expressed mRNAs to the chemical and genetic
perturbations (CPG) database, we observed significant overlap
between genes downregulated by Hp1bp3 KD and those genes
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F IGURE 3 Hp1bp3 KD negatively
regulates neuronal synaptic plasticity. (a)
Enrichment plot illustrating enrichment of
the GO term regulation of neuronal
synaptic plasticity among genes
downregulated by Hp1bp3 KD. Enrichment
score = −0.6, Normalized enrichment
score = −2.2, FDR = 0.01. (b) The core
driver gene most significantly
downregulated by Hp1bp3 KD, particularly
in B6 mice, was Arc (DESeq2 effect of
treatment; log2FC = −1.2, adjusted
p = 0.001, effect of strain; log2FC = −1.2,
adjusted p = 0.001, interaction adjusted
p = 0.2). (c) A number of plasma membrane
proteins, particularly ion channels and
receptors, were identified as additional
core drivers of this enrichment. *DESeq2
main effect of treatment, p < 0.05
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downregulated with age in the human frontal cortex [(Lu et al.,
2004), FDR q‐value = 0.04, Figure 6a]. This significant enrichment
was driven by 43 genes significantly downregulated in both the
aging human frontal cortex and the mouse hippocampus following
Hp1bp3 KD, 37 of which were determined by GSEA to be core dri-
vers of enrichment. The twenty most significantly downregulated
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current injection, and the slow after‐hyperpolarization was recorded 1 s after the last stimulus offset. sAHPs were not different across B6 and
D2 mice [effect of strain, F(1,56) = 0.1, p = 0.7] so data presented are pooled across strains. A significant effect of treatment was detected [F
(1, 56) = 6.7, p = 0.01], indicating that across strains, Hp1bp3 increases the sAHP. (b) Representative traces from Ctrl and KD animals. (c)
Diagram of recording configuration for synaptic experiments. A stimulating electrode was placed in the Shaffer collateral leading from CA3 to
CA1. Single neurons were recorded from in CA1 using whole‐cell patch‐clamp electrophysiology. (d) Excitatory postsynaptic potentials (EPSPs)
were evoked once every 20 s for five minutes to obtain a stable baseline measure (BL). Theta‐burst stimulation (TBS) was delivered and EPSPs
continued to be evoked and measured every 20 s for 35 min. Data were pooled into five‐minute bins for further analysis. A significant within‐
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Hp1bp3 knockdown impaired LTP similarly across strains. (e) Representative traces from B6 Ctrl, (f) B6 KD, (g) D2 Ctrl, and (h) D2 KD animals
both pre‐ and post‐TBS
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core drivers, as well as their corresponding fold changes from the
human brain (Lu et al., 2004), are listed in Figure 6b. As a group, this
set of commonly downregulated genes displayed relatively diverse
enrichment for GO Biological Process terms using WebGestalt over‐
representation enrichment analysis (Wang et al., 2013), including
interleukin secretion (IL‐5 FDR = 0.03, IL‐13 FDR = 0.03), micro-
tubule polymerization (FDR = 0.04), and chemical synaptic transmis-
sion (FDR = 0.04), all processes known to be altered in aging.
Combined with our previous observation that HP1BP3 expression is
decreased in cognitively impaired aging humans, the overlap of the
broader Hp1bp3 KD transcriptome with that of human aging sup-
ports the idea that Hp1bp3 is a critical regulator of a number of the
transcriptional changes that occur during aging and may serve as a
valuable therapeutic target to delay or prevent aging‐related cogni-
tive decline.
3 | DISCUSSION
3.1 | Hippocampal Hp1bp3 regulates cognitive
function, gene transcription, and synaptic plasticity
Here, we demonstrate for the first time that a targeted knockdown
of Hp1bp3 in the hippocampus by 50%–75% was sufficient to
recapitulate cognitive deficits observed previously in global Hp1bp3
knockout mice (Neuner et al., 2016).
Specifically, in both cases, we observed impairments in both spa-
tial working memory and contextual fear memory, but not in contex-
tual fear acquisition. This implicates a relatively specific role for
Hp1bp3 in mechanisms underlying working memory as well as mem-
ory consolidation and recall, but highlights that contextual fear
acquisition may rely on independent mechanisms for successful com-
pletion. Overall, results here demonstrate that cognitive deficits
caused by Hp1bp3 deficiency, presumably in both KO mice and aged
impaired mice, are due primarily to Hp1bp3 deficiency in the hip-
pocampus. This is an important finding, as Hp1bp3 knockout mice
are smaller than WT littermates and have alterations in insulin signal-
ing that may have impacted cognitive performance due to peripheral
mechanisms (Garfinkel, Arad, et al., 2015). In addition, we extend our
previous finding that loss of Hp1bp3 has a negative impact in cogni-
tive function and provide mechanistic insight into how these alter-
ations occur. Specifically, we show Hp1bp3 KD negatively regulates
a number of genes critical for synaptic plasticity and neuronal activ-
ity, including the immediate early gene Arc (Figure 2b). Although Arc
is well‐known to be critical for memory formation (Guzowski et al.,
2000; Plath et al., 2006), the precise signaling cascades involved in
Arc transcription and regulation are not well‐defined (Shepherd &
Bear, 2011).
Here, we discover a novel role for Hp1bp3 as a regulator of Arc
expression, which implicates Hp1bp3 in the broader context as a
master regulator of transcriptional network changes required for suc-
cessful induction of synaptic plasticity, likely via its role in modifying
chromatin structure (Dutta et al., 2014). Finally, we demonstrate that
observed transcriptional changes functionally manifest as impair-
ments in both intrinsic neuronal excitability and synaptic plasticity.
Together, these results provide important insight into physiological
functions of Hp1bp3 under baseline conditions in adult mice. As a
result, we can now better understand how misregulation of Hp1bp3
may contribute to cognitive impairments seen in both Hp1bp3
TABLE 1 Basic intrinsic excitability characteristics across groups
Group RMP (mV) IR (MΩ)
APthreshold
(mV)
AHPpeak
(mV)
B6 Ctrl −64.3 ± 0.5 154.8 ± 8.7 −50.0 ± 0.7 −4.2 ± 0.6
B6 KD −64.0 ± 0.5 135.0 ± 10.0 −50.5 ± 1.0 −4.2 ± 0.5
D2
Ctrl
−62.3 ± 0.5 192.9 ± 15.6 −48.6 ± 0.6 −5.1 ± 0.6
D2 KD −61.3 ± 0.2 188.8 ± 0.9 −48.9 ± 0.8 −4.6 ± 0.5
Note. AHP: after hyperpolarization; AP: action potential; Ctrl: control; IR:
input resistance; KD: knockdown; mV: millivolts; MΩ: megaohms; RMP:
resting membrane potential.
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F IGURE 5 Hp1bp3 selectively regulates the miRNA transcriptome in vivo. (a) Plot illustrating (x‐axis) average miRNA expression versus (y‐
axis) log fold change as measured by DESeq2. Red dots illustrate those miRNA transcripts that were determined to be differentially expressed
relative to treated at an adjusted p = 0.10. (b) miRNA mmu‐mir‐223‐3p was identified as a putative upstream regulator of observed mRNA
changes after Hp1bp3 KD and was predicted to be activated in our dataset by IPA. mmu‐mir‐223‐3p was significantly upregulated by Hp1bp3
knockdown [*two‐way ANOVA, effect of treatment F(1, 8) = 5.6, p = 0.046, no significant effect of strain or interaction between strain and
treatment]
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knockout mice and cognitively impaired aging mice and humans with
decreased levels of Hp1bp3 (Neuner et al., 2016).
3.2 | Hp1bp3 effect on cognition and neural
function is robust to genetic context
It has long been known that genetic background is critical for modi-
fying phenotypic presentation. Recently, this was highlighted by a
survey of 30 inbred lines, where in some cases, opposite conclusions
were drawn regarding the effect of gene knockout depending on the
genetic context of the manipulation (Sittig et al., 2016). Therefore,
we thought it important to evaluate the effect of Hp1bp3 manipula-
tion in more than one genetic background. We performed our exper-
iments in the B6 and D2 inbred strains, as these strains were used
to derive the BXD genetic reference panel which was originally used
for identifying Hp1bp3 as a modifier of cognitive aging. These two
strains show marked differences in learning and memory abilities
(Neuner et al., 2016; Philip et al., 2010) as well as differences in cer-
tain types of LTP (Matsuyama et al., 1997; Nguyen et al., 2000). In
general, our data are consistent with this literature, with the B6
strain outperforming the D2 strain on contextual fear conditioning.
While we demonstrate here TBS is capable of inducing LTP in both
strains, other types of LTP have been shown to be reduced in the
D2 strain (Schimanski & Nguyen, 2005), which may explain their
poor performance on contextual fear conditioning—a task which
requires synaptic plasticity (Tang et al., 1999). Poor performance on
contextual fear conditioning may also be explained, in part, by lower
baseline levels of Hp1bp3 mRNA observed in the D2 strain (Fig-
ure 2a), which while not detected at the protein level (Figure 1b), is
consistent with our previous findings that BXD strains carrying the
D allele of Hp1bp3 show decrease hippocampal Hp1bp3 expression.
As Hp1pb3 knockdown impaired cognitive function and reduced
neuronal excitability in both strains, as well as largely affected the
transcriptome across strains similarly (Figure 2b), our data suggest
Hp1bp3 deficiency has a robust detrimental effect on cognitive func-
tion regardless of genetic context. This broadens the translational
relevance of this finding, as restoring Hp1bp3 levels (or supplement-
ing with a small molecule that increases Hp1bp3 levels [e.g., Met-
formin (Neuner et al., 2016)]), is likely to be beneficial to a wider
variety of subjects than a target with context‐dependent effects.
3.3 | Hp1bp3 as a regulator of miRNA biogenesis
Contrary to previous reports (Liu et al., 2016), Hp1bp3 does not
seem to be a global regulator of miRNA biogenesis, at least in the
adult mouse hippocampus. Multiple explanations for these conflicting
results exist, including different experimental species (mouse vs.
human), differences in experimental techniques (in vitro vs. in vivo),
and even differences in miRNA alignment protocols. In addition, we
did observe a select set of miRNAs differentially expressed relative
to Hp1bp3 KD, suggesting Hp1bp3 does regulate biogenesis of at
least some miRNAs in vivo. Of particular interest to this study is
mir‐223, which was identified by IPA as a putative upstream regula-
tor of observed mRNA‐level changes following Hp1bp3 KD and
whose expression in our miRNA sequencing data changed concor-
dantly with that predicted by IPA. As a number of immune‐related
genes have been shown to be downregulated in mir‐223 deficient
cells (Lu et al., 2013), the large number of immune‐related genes
upregulated after Hp1bp3 KD may, in part, be due to observed
upregulation of mmu‐mir‐223‐3p. While mir‐223 is best studied in
the context of the hematopoietic system, recent studies have inves-
tigated its role in CNS functions and it has recently been shown to
be enriched in the hippocampus relative to other brain regions (Har-
raz, Eacker, Wang, Dawson, & Dawson, 2012). In particular, mir‐
223 has been shown to decrease total dendritic tree length, branch
number, and complexity in cell culture (Harraz, Xu, Guiberson, Daw-
son, & Dawson, 2014) and specifically target glutamate receptor
transcripts for degradation in vivo (Harraz et al., 2012), which may
link mir‐223 to some of the additional neuronal phenotypes
observed in Hp1bp3 KD mice. In summary, while miRNA biogenesis
likely contributes to some of the transcriptional changes observed
after Hp1bp3 KD, additional mechanisms regulating gene expression
are likely at play, including alterations in chromatin structure that
result in changes in the accessibility of key genomic regions to nec-
essary transcriptional machinery.
3.4 | Hp1pb3 knockdown recapitulates symptoms
of aging and Alzheimer's disease
Many alterations observed after Hp1bp3 KD appear to phenocopy
alterations observed in aging and Alzheimer's disease (AD). In
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F IGURE 6 Transcriptome‐level changes
induced by Hp1bp3 knockdown
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aging. (a) Enrichment plot illustrating
overlap of genes downregulated in the
human aging cortex with genes among
genes downregulated by Hp1bp3 KD.
Enrichment score = −0.4, Normalized
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reported by Lu et al. (2004)
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particular, studies have identified decreases in neuronal excitability
as cellular correlates of cognitive impairments in aging animals (Dis-
terhoft, Wu, & Ohno, 2004). Notably, the sAHP is increased in aged
impaired animals relative to young and aged nonimpaired animals
(Kaczorowski & Disterhoft, 2009). Similar neuronal phenotypes have
been observed in animal models of AD (Kaczorowski, Sametsky,
Shah, Vassar, & Disterhoft, 2011). As these aged and AD neurons
are less able to respond adequately to input, this reduced neuronal
excitability translates into a reduction in the maintenance of LTP and
poorer memory storage. Transcriptionally, mRNA changes after
Hp1bp3 KD significantly overlap mRNA changes observed in the
aging human cortex [FDR < 0.05, Figure 6, (Lu et al., 2004)] and are
reminiscent of increased inflammation and neurodegeneration
observed in AD patients (Van Eldik et al., 2016). In addition, baseline
reductions in Arc expression have been observed in aging rodents,
which correlates with less efficient memory storage and retrieval
during aging (Penner et al., 2011). Each of these hallmark features of
aging and AD—decreased neuronal excitability, reduced synaptic
plasticity, impaired cognitive function, and increased neuroinflamma-
tion—is recapitulated in our Hp1bp3 KD animals. Together with our
previous observations that cognitively impaired mice and humans
have naturally occurring reductions in Hp1bp3 levels, our data sug-
gest reduced Hp1bp3 is a relevant driver of aging and AD‐related
phenotypes. As aging is the leading risk factor for many disease in
addition to AD, and there is currently no cure for AD, understanding
the origin of these deficits is critical for developing effect therapeu-
tics to maintain healthspan in aging individuals. The identification
and characterization of Hp1bp3’s effect on cognition and neural
function under baseline adult conditions are a critical first step
toward understanding how aging, Hp1bp3, and additional genetic
and environmental factors interact to modify an individual's suscepti-
bility to age‐related cognitive decline.
4 | CONCLUSIONS AND FUTURE
DIRECTIONS
Overall, our data support a critical role for Hp1bp3 in modifying cog-
nition and neuronal function, as well as the transcriptional programs
underlying both. These results further contribute to our understand-
ing of both physiological functions of Hp1bp3 and molecular media-
tors of memory formation and storage, as well as some of the
hallmark symptoms of aging. In addition to the selective regulation
of gene expression, previous studies have implicated Hp1bp3 in the
regulation of chromatin structure (Dutta et al., 2014). Recent studies
have demonstrated that long‐term maintenance of chromatin struc-
ture is critical for maintenance of cognitive longevity (Lopez‐Otin,
Blasco, Partridge, Serrano, & Kroemer, 2013), providing an additional
mechanism Hp1bp3 may work through in order to influence cogni-
tive aging. Future studies will address this possibility directly with
targeted ATAC‐seq (an assay for transposase accessible chromatin
with high‐throughput sequencing) in order to assess how chromatin
accessibility changes with Hp1bp3 KD. The discoveries made here,
as well as in future studies, will help inform the development of
therapeutics designed to target either Hp1bp3 or its downstream
effectors (such as those plasma membrane ion channels and recep-
tors highlighted in Figure 3c) in order to help promote cognitive
longevity and reduce the risk of multiple age‐related diseases.
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